Skip to main content
Premium Trial:

Request an Annual Quote

DNAPrint Genomics Forms Pharmacogenomics Collaboration with Moffitt Cancer Center

NEW YORK, March 29 (GenomeWeb News) - DNAPrint Genomics said today that it has formed a pharmacogenomics collaboration with the H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida.


The partnership, said DNAPrint, will focus on developing and implementing new tests for predicting patient response to various cancer chemotherapies.


A primary area of focus for the effort will be colorectal cancer, the company said, although other cancers will explored.


The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.